What else would you like announced? They have published a timeline, and announcements so far are inline with that.
We are in a period of waiting for information from third parties. They being the European and American regulators with guidance on the next trial/trials.
As Sam says, for now we wait.
Ann: US FDA Type C Meeting for ATL1102 in DMD, page-88
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
0.002(2.22%) |
Mkt cap ! $81.13M | |||
| Open | High | Low | Value | Volume |
| 8.9¢ | 9.2¢ | 8.8¢ | $69.28K | 764.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1079 | 9.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.2¢ | 87277 | 2 |
View Market Depth
| Last trade - 15.59pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
9.2¢ |
Change
0.002 ( 3.37 %) |
||||
| Open | High | Low | Volume | ||
| 8.9¢ | 9.2¢ | 8.8¢ | 138646 | ||
| Last updated 15.59pm 14/06/2024 ? | |||||
| PER (ASX) Chart |